Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Zbrzeźniak J"'
Autor:
Mrozowska-Nyckowska K; Zakład Epidemiologii Chorób Zakaźnych i Nadzoru, Narodowy Instytut Zdrowia Publicznego - Państwowy Zakład Higieny w Warszawie, Polska., Zbrzeźniak J; Zakład Epidemiologii Chorób Zakaźnych i Nadzoru, Narodowy Instytut Zdrowia Publicznego - Państwowy Zakład Higieny w Warszawie, Polska., Paradowska-Stankiewicz I; Zakład Epidemiologii Chorób Zakaźnych i Nadzoru, Narodowy Instytut Zdrowia Publicznego - Państwowy Zakład Higieny w Warszawie, Polska.
Publikováno v:
Przeglad epidemiologiczny [Przegl Epidemiol] 2024 Sep 18; Vol. 78 (2), pp. 219-234. Date of Electronic Publication: 2024 Jul 19.
Autor:
Paradowska-Stankiewicz I; National Institute of Public Health-National Institute of Hygiene-National Research Institute, Department of Infectious Disease Epidemiology and Surveillance, Warsaw, Poland., Zbrzeźniak J; National Institute of Public Health-National Institute of Hygiene-National Research Institute, Department of Infectious Disease Epidemiology and Surveillance, Warsaw, Poland., Skufca J; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium., Nagarajan A; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium., Ochocka P; National Institute of Public Health-National Institute of Hygiene-National Research Institute, Department of Infectious Disease Epidemiology and Surveillance, Warsaw, Poland., Pilz A; Pfizer Global Medical Affairs, Vaccines, Vienna, Austria., Vyse A; Patient and Health Impact, Pfizer R&D UK LTD, Walton Oaks, United Kingdom., Begier E; Vaccine Clinical Research and Development, Pfizer Inc, Pearl River, New York, USA., Dzingina M; Patient and Health Impact, Pfizer R&D UK LTD, Walton Oaks, United Kingdom., Blum M; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium., Riera-Montes M; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium., Gessner BD; Vaccine Medical Development & Scientific/Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA., Stark JH; Vaccine Medical Development & Scientific/Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA.
Publikováno v:
Vector borne and zoonotic diseases (Larchmont, N.Y.) [Vector Borne Zoonotic Dis] 2023 Apr; Vol. 23 (4), pp. 247-255. Date of Electronic Publication: 2023 Jan 27.
Autor:
Van Heuverswyn J; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden., Hallmaier-Wacker LK; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden., Beauté J; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden., Gomes Dias J; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden., Haussig JM; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden., Busch K; Public Health Agency of Sweden, Stockholm, Sweden., Kerlik J; Regional Authority of Public Health in Banská Bystrica, Banská Bystrica, Slovakia., Markowicz M; Austrian Agency for Health and Food Safety, Vienna, Austria., Mäkelä H; Finnish Institute for Health and Welfare, Helsinki, Finland., Nygren TM; Robert Koch Institute (RKI), Berlin, Germany., Orlíková H; National Institute of Public Health, Prague, Czechia., Socan M; National Institute of Public Health, Ljubljana, Slovenia., Zbrzeźniak J; National Institute of Public Health - NIH - National Research Institute, Warsaw, Poland., Žygutiene M; National Public Health Center under the Ministry of Health, Vilnius, Lithuania., Gossner CM; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Publikováno v:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2023 Mar; Vol. 28 (11).
Autor:
Mrozowska-Nyckowska K; National Institute of Public Health NIH - National Research Institute, Department of Epidemiology of Infectious Diseases and Surveillance., Zbrzeźniak J; National Institute of Public Health NIH - National Research Institute, Department of Epidemiology of Infectious Diseases and Surveillance., Paradowska-Stankiewicz I; National Institute of Public Health NIH - National Research Institute, Department of Epidemiology of Infectious Diseases and Surveillance.
Publikováno v:
Przeglad epidemiologiczny [Przegl Epidemiol] 2023; Vol. 77 (3), pp. 387-402.
Autor:
Zbrzeźniak J; National Institute of Public Health NIH - National Research Institute Department of Epidemiology of Infectious Diseases and Surveillance., Paradowska-Stankiewicz I; National Institute of Public Health NIH - National Research Institute Department of Epidemiology of Infectious Diseases and Surveillance.
Publikováno v:
Przeglad epidemiologiczny [Przegl Epidemiol] 2023; Vol. 77 (3), pp. 381-386.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mrozowska-Nyckowska K; National Institute of Public Health NIH - National Research Institute, Department of Epidemiology of Infectious Diseases and Surveillance., Zbrzeźniak J; National Institute of Public Health NIH - National Research Institute, Department of Epidemiology of Infectious Diseases and Surveillance., Paradowska-Stankiewicz I; National Institute of Public Health NIH - National Research Institute, Department of Epidemiology of Infectious Diseases and Surveillance.
Publikováno v:
Przeglad epidemiologiczny [Przegl Epidemiol] 2022; Vol. 76 (3), pp. 371-384.
Autor:
Zbrzeźniak J; National Institute of Public Health NIH - National Research Institute, Department of Epidemiology of Infectious Diseases and Surveillance., Paradowska-Stankiewicz I; National Institute of Public Health NIH - National Research Institute, Department of Epidemiology of Infectious Diseases and Surveillance.
Publikováno v:
Przeglad epidemiologiczny [Przegl Epidemiol] 2022; Vol. 76 (3).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Paradowska-Stankiewicz I; National Institute of Public Health National Institute of Hygiene - National Research Institute, ul. Chocimska 24, 00-791 Warsaw, Poland. Electronic address: istankiewicz@pzh.gov.pl., Rumik A; National Institute of Public Health National Institute of Hygiene - National Research Institute, ul. Chocimska 24, 00-791 Warsaw, Poland., Bogusz J; National Institute of Public Health National Institute of Hygiene - National Research Institute, ul. Chocimska 24, 00-791 Warsaw, Poland., Zbrzeźniak J; National Institute of Public Health National Institute of Hygiene - National Research Institute, ul. Chocimska 24, 00-791 Warsaw, Poland., Rastawicki W; National Institute of Public Health National Institute of Hygiene - National Research Institute, ul. Chocimska 24, 00-791 Warsaw, Poland., Śmietańska K; National Institute of Public Health National Institute of Hygiene - National Research Institute, ul. Chocimska 24, 00-791 Warsaw, Poland., Vargas-Zambrano JC; Sanofi Pasteur, 14 espace Henry Vallée, 69007 Lyon, France. Electronic address: juan.vargas@sanofi.com., Macina D; Sanofi Pasteur, 14 espace Henry Vallée, 69007 Lyon, France. Electronic address: denis.macina@sanofi.com.
Publikováno v:
Vaccine [Vaccine] 2021 Oct 01; Vol. 39 (41), pp. 6067-6073. Date of Electronic Publication: 2021 Sep 10.